As a hallmark cytokine in CD8+ T-cell activation and tumor infiltration (69), the synergistic effects of the combination treatment with both immunoadjuvants increased the tumoral expression of TNF-α twofold, whereas reduced expression of this cytokine was detected when single forms of immunoadjuvants were administered (Figure 2D). Here, TNF is linked to neoplasm.